Otitis media: Inflammation of the anatomical structures of the middle ear, which is most often caused by an infectious process. Symptoms include erythema and edema of the tympanic membrane, pain, and possibly fever.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
192 |
4. Check minimum number of eventsNone |
192 |
5. Include endpointsNone |
192 |
6. Filter based on genotype QC (FinnGen only) |
192 |
Control definitions (FinnGen only)
- Control exclude
- H8_MIDDLEMASTOID
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H74
- Name in latin
- Discontinuitas ossiculorum auditoriorum
Similar endpoints
↥List of similar endpoints to
Discontinuity and dislocation of ear ossicles
based on the number of shared cases.
Similar with more cases:
- Diseases of middle ear and mastoid
- Diseases of the ear and mastoid process
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1329 | 614 | 704 |
| Only index persons | 1268 | 593 | 675 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.02 | 0.02 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 44.71 | 48.15 | 41.81 |
| Only index persons | 45.31 | 48.21 | 42.77 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 192 | 103 | 89 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 51.77 | 50.09 | 53.72 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 167
- Matched controls
- 1671
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H74.2
ICD-10 Finland
Discontinuity and dislocation of ear ossicles
+∞
241.5
167
*
DCD10
NOMESCO Finland
Tympanoplasty
+∞
83.5
73
*
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
243.7
64.0
62
*
H71
ICD-10 Finland
Cholesteatoma of middle ear
+∞
49.4
45
*
DFF00
NOMESCO Finland
Pure tone audiometry
20.2
48.5
78
69
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
603.3
47.8
45
*
UDC00
NOMESCO Finland
Ear microscopy
21.7
40.1
61
43
DC1AD
NOMESCO Finland
Temporalbone CT
243.6
38.5
38
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
8.7
28.1
69
124
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
+∞
27.9
26
*
DDD05
NOMESCO Finland
Plastic repair of ossicular chain
+∞
26.8
25
*
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
79.8
24.6
27
*
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
63.8
23.9
27
5
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
+∞
23.5
22
*
DCD00
NOMESCO Finland
Myringoplasty
+∞
22.4
21
*
ZXC10
NOMESCO Finland
Use of laser
20.3
19.5
29
17
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
79.3
19.2
21
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
13.9
19.0
33
29
DEA10
NOMESCO Finland
Attico-antrotomy
+∞
16.9
16
*
H74.1
ICD-10 Finland
Adhesive middle ear disease
+∞
15.9
15
*
H65.2
ICD-10 Finland
Chronic serous otitis media
+∞
15.9
15
*
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
+∞
15.9
15
*
H65.3
ICD-10 Finland
Chronic mucoid otitis media
+∞
14.8
14
*
Z3229
NOMESCO Finland
Other healthcare associate professional
7.1
14.2
36
62
H80.0
ICD-10 Finland
Otosclerosis involving oval window, nonobliterative
43.9
13.4
16
*
H80.9
ICD-10 Finland
Otosclerosis, unspecified
75.7
12.8
14
*
DDD10
NOMESCO Finland
Interposition between malleus and stapes
+∞
12.7
12
*
DFF15
NOMESCO Finland
Speech audiometry
10.2
12.2
24
27
DEB25
NOMESCO Finland
Attico-antro-mastoidectomy and tympanoplasty
+∞
11.6
11
*
H74.3
ICD-10 Finland
Other acquired abnormalities of ear ossicles
+∞
11.6
11
*
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
46.7
11.1
13
*
H70.1
ICD-10 Finland
Chronic mastoiditis
+∞
10.5
10
*
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
9.7
10.1
20
23
H72.9
ICD-10 Finland
Perforation of tympanic membrane, unspecified
42.8
10.1
12
*
DDA00
NOMESCO Finland
Stapedotomy
105.6
9.5
10
*
4150
FHL
Tympanoplasty (including for reasons other than inflammation)
+∞
9.5
9
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.1
9.4
39
116
WX110
NOMESCO Finland
Local anesthesy
3.1
8.8
134
947
Z97.4
ICD-10 Finland
Presence of external hearing-aid
10.9
8.7
16
16
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
+∞
8.4
8
*
ZXA00
NOMESCO Finland
Right side
2.8
7.8
61
285
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
5.8
7.7
21
40
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
7.6
65
321
H29
ICPC
Ear symptom/complaint other
4.2
7.6
29
80
H01
ICPC
Ear pain/earache
3.9
7.5
31
92
H69.0
ICD-10 Finland
Patulous Eustachian tube
+∞
7.3
7
*
DGW00
NOMESCO Finland
Dilatation of eustachian tube
+∞
7.3
7
*
H95.8
ICD-10 Finland
Other postprocedural disorders of ear and mastoid process
+∞
7.3
7
*
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
+∞
7.3
7
*
TDA90
NOMESCO Finland
Removal wax from ear
23.6
6.7
9
*
H66.9
ICD-10 Finland
Otitis media, unspecified
6.7
6.6
16
26
H91.9
ICD-10 Finland
Hearing loss, unspecified
6.4
6.5
16
27
ZZG00
NOMESCO Finland
Graft of cartilage
72.4
6.5
7
*
R5120
NOMESCO Finland
Preparation of an aid
9.8
6.4
12
13
DAX08
NOMESCO Finland
Fitting of hearing aid
7.5
6.4
14
20
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
27.8
6.3
8
*
4122
FHL
Tympanostomy (tympanic tube)
+∞
6.3
6
*
4141
FHL
Myringoplasty (also for reasons other than inflammation)
+∞
6.3
6
*
H73.1
ICD-10 Finland
Chronic myringitis
+∞
6.3
6
*
H65.4
ICD-10 Finland
Other chronic nonsuppurative otitis media
+∞
6.3
6
*
H95.1
ICD-10 Finland
Other disorders following mastoidectomy
+∞
6.3
6
*
38199
ICD-8 Finland
Otitis media without mention of mastoiditis, Unspecified
+∞
6.3
6
*
DBD10
NOMESCO Finland
Reconstruction of external auditory canal
+∞
6.3
6
*
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
+∞
6.3
6
*
DCW99
NOMESCO Finland
Other operation on eardrum and middle ear
+∞
6.3
6
*
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
10.6
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
38
153
2.85
6.97
2.5
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
19
65
3.13
4.59
9.0
8.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
87
648
1.63
2.75
5.0
5.3
mmol/l
1.2
1.2
0.21
79
590
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
31
171
1.97
2.75
4.2
4.2
%
28.1
31.7
1.32
20
102
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
79
578
1.62
2.67
1.9
1.8
pmol/l
104.2
95.7
0.45
36
282
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
92
699
1.61
2.66
5.2
6.3
mmol/l
1.2
1.2
0.08
77
592
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
43
268
1.78
2.62
4.0
3.4
ng/l
119.6
135.0
0.06
34
186
(3021589) Normoblasts [#/volume] in Blood
50
716
0.59
2.59
9.2
9.1
e9/l
0.0
0.0
0.43
42
573
(3000494) Fungus identified in Specimen by Culture
30
169
1.92
2.51
1.8
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
17
81
2.21
2.20
7.0
4.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
43
2.65
2.13
4.7
2.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
19
341
0.51
2.11
5.6
5.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
44
615
0.63
1.93
2.5
2.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
130
1117
1.51
1.89
3.0
3.0
u/l
52.3
47.3
0.26
123
1050
(3041096) Erythrocytes [Presence] in Urine by Automated
29
437
0.60
1.72
2.8
3.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
151
1.75
1.70
1.7
1.7
—
—
—
0
0
(3019225) pH of Specimen
22
128
1.81
1.69
2.1
4.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
32
456
0.64
1.48
3.5
2.9
e6/l
102.7
42.7
0.32
25
349
(3013707) Erythrocyte sedimentation rate by Westergren method
132
1166
1.42
1.45
4.1
3.9
mm/h
12.4
11.0
0.43
125
1086
(3048689) Calprotectin [Mass/mass] in Stool
30
202
1.57
1.38
1.6
2.3
ug/g
61.1
119.5
1.41
22
162
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
134
1192
1.41
1.37
5.7
7.3
u/l
79.3
78.8
0.03
122
1114
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
17
2.99
1.36
1.2
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
86
716
1.36
1.30
3.5
3.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
18
2.82
1.29
1.6
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
30
207
1.53
1.25
1.6
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
6
127
0.46
1.22
3.0
3.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
46
590
0.71
1.21
3.3
3.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
5
111
0.44
1.17
4.8
3.8
mmol/l
1.3
1.2
—
5
102
(4010399)
18
111
1.69
1.17
1.6
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
160
1485
1.46
1.16
14.8
13.0
%
39.8
40.6
0.50
115
1130
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
162
1510
1.47
1.12
4.6
4.4
mmol/l
5.8
5.9
0.86
147
1395
(3021788) Differential panel - Synovial fluid
5
21
2.42
1.09
1.4
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
47
364
1.39
1.09
1.6
2.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
73
608
1.32
1.06
2.2
2.3
nmol/l
72.9
75.7
0.30
65
535
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
9
46
2.00
1.05
1.2
1.1
—
3.6
—
0
7
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
22
2.31
1.04
1.0
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
22
2.31
1.04
1.0
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
22
2.31
1.04
1.0
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
47
1.96
1.03
1.3
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
45
351
1.37
1.00
1.6
1.5
nmol/l
18.4
21.6
0.89
38
301
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
29
0.00
0.98
0.0
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
49
389
1.35
0.98
3.6
4.4
%
23.5
21.7
0.27
19
184
(3030467) Casts [#/volume] in Urine by Automated count
31
411
0.71
0.97
3.6
2.7
e6/l
0.1
0.4
1.64
24
301
(40761511) CBC panel - Blood by Automated count
176
1678
1.59
0.97
12.1
11.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
169
1599
1.48
0.95
14.2
13.8
mmol/l
139.8
139.7
0.16
163
1559
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
43
336
1.36
0.95
2.0
2.0
mg/l
2.2
3.2
2.72
36
292
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
58
475
1.32
0.94
2.6
2.3
u/l
58.7
56.4
0.14
52
431
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
155
1451
1.35
0.88
4.9
4.5
mu/l
1.8
1.9
0.64
140
1329
(3000475) Leukocytes [#/volume] in Synovial fluid
6
30
2.03
0.87
1.3
1.5
e6/l
3555.3
14773.3
—
6
20
(42870588) Differential panel, method unspecified - Blood
61
508
1.29
0.87
6.6
5.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
6
111
0.53
0.86
2.8
2.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
92
808
1.27
0.86
3.9
6.1
umol/l
9.8
11.2
0.90
85
766
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
45
1.81
0.85
1.1
1.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
31
1.96
0.85
1.5
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
32
411
0.73
0.83
3.6
2.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
42
517
0.76
0.81
3.0
2.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
169
1609
1.42
0.81
14.4
13.9
mmol/l
4.0
4.0
0.16
163
1563
(3013512) EKG study
49
400
1.30
0.81
2.8
3.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
33
1.84
0.79
1.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
32
246
1.36
0.79
1.4
1.6
nmol/l
899.2
1156.8
1.13
27
188
(3022096) Basophils/100 leukocytes in Blood
81
708
1.25
0.77
6.6
5.9
%
0.7
0.7
0.49
75
662
(3017446) Testosterone [Moles/volume] in Serum or Plasma
8
133
0.58
0.76
2.6
2.1
nmol/l
11.6
14.6
—
8
128
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
178
1715
1.52
0.75
9.5
9.8
u/l
29.2
27.6
0.29
171
1670
(3018095) Leukocytes [#/volume] in Urine
44
532
0.78
0.74
4.0
3.4
e6/l
28.7
53.6
0.48
27
373
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
56
1.64
0.73
1.3
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
25
2.03
0.73
1.2
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
167
1593
1.37
0.73
4.9
4.7
mmol/l
2.9
2.8
0.94
151
1482
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
128
1183
1.25
0.71
4.0
3.9
pmol/l
14.5
14.7
0.62
116
1074
(3037467) Urinalysis macro (dipstick) panel - Urine
114
1042
1.23
0.70
5.0
3.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
94
1.53
0.69
1.1
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
75
658
1.23
0.68
2.7
2.6
ug/l
123.1
113.2
0.20
69
608
(36660697) Celiac disease serology panel - Serum
19
137
1.43
0.67
1.3
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
43
1.65
0.67
1.0
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
28
1.81
0.66
1.4
1.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
28
1.81
0.66
1.2
4.4
—
848.0
—
0
5
(3019230) Fractional oxyhemoglobin in Venous blood
5
28
1.81
0.66
1.0
1.9
%
71.7
66.1
—
5
28
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
57
487
1.24
0.65
4.2
4.8
ug/l
1.6
2.0
1.04
50
436
(40760888) Immunoglobulin light chains.free panel - Serum
5
29
1.74
0.64
1.2
3.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
103
0.57
0.64
1.0
1.3
—
—
—
0
0
(4035726)
9
140
0.63
0.63
1.2
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
51
1.59
0.61
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
22
0.00
0.59
0.0
1.9
—
91.0
—
0
22
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
8
54
1.50
0.58
3.4
3.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
88
0.56
0.57
1.4
1.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
10
65
1.57
0.56
6.6
7.0
mmol/l
24.8
24.6
—
10
59
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
6
39
1.56
0.53
2.0
1.9
g/l
0.0
0.0
—
6
39
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
6
39
1.56
0.53
2.0
1.9
g/l
0.0
0.0
—
6
39
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
152
1450
1.23
0.52
5.3
5.4
mmol/mol
38.8
39.6
0.63
141
1353
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
29
236
1.27
0.50
1.3
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
33
394
0.80
0.50
1.4
1.2
u/ml
0.7
0.9
—
7
113
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
45
1.58
0.49
1.3
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
28
340
0.79
0.49
1.2
1.4
g/l
2.9
2.6
0.38
17
207
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
21
165
1.31
0.47
1.3
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
99
1063
0.86
0.46
4.4
3.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
163
1574
1.24
0.44
4.6
4.3
mmol/l
4.8
4.7
1.30
149
1474
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
57
1.42
0.42
2.1
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
20
159
1.29
0.42
1.4
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
15
114
1.34
0.42
5.9
6.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
33
1.53
0.41
2.2
2.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
162
1566
1.22
0.41
4.5
4.2
mmol/l
1.5
1.5
0.00
147
1456
(4268621)
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
0
15
0.00
0.41
0.0
1.8
—
0.2
—
0
10
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
0
16
0.00
0.41
0.0
1.8
—
434.0
—
0
10
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
17
0.00
0.41
0.0
2.1
—
445.0
—
0
7
(3006315) Basophils [#/volume] in Blood
85
784
1.15
0.40
6.1
6.0
e9/l
0.0
0.0
1.42
77
685
(40768806) Pleura Pathology biopsy report
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
35
1.44
0.39
1.2
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
19
0.00
0.39
0.0
2.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
19
0.00
0.39
0.0
2.6
—
106.0
—
0
19
(3041354) Potassium [Moles/volume] in Venous blood
0
19
0.00
0.39
0.0
2.6
—
4.0
—
0
19
(3023511) Choriogonadotropin [Units/volume] in Urine
5
36
1.40
0.38
1.4
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
72
1.41
0.37
3.2
2.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
158
1529
1.19
0.36
3.8
3.8
mmol/l
1.3
1.3
0.28
145
1408
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
6
42
1.44
0.36
2.0
1.9
g/l
0.0
0.1
—
6
42
(46235355) HIV 1 and 2 tests - Meaningful Use set
29
338
0.83
0.36
1.8
1.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
53
477
1.15
0.35
1.7
2.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
48
429
1.16
0.34
2.0
2.0
u/l
165.5
204.7
0.29
43
407
(3011397) Hemoglobin [Presence] in Urine by Test strip
39
343
1.17
0.34
3.3
3.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
31
268
1.19
0.33
1.3
1.3
iu/ml
66.8
24.4
—
7
95
(3015736) pH of Urine
62
567
1.14
0.32
3.0
3.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
54
1.31
0.31
1.1
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
57
1.24
0.29
1.4
2.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
10
128
0.77
0.27
1.6
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
11
86
1.30
0.27
1.1
1.3
—
—
—
0
0
(3012544) pH of Venous blood
16
132
1.23
0.26
2.9
3.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
86
811
1.11
0.26
6.3
6.3
e9/l
0.2
0.2
0.08
80
721
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
5
71
0.70
0.26
1.6
2.6
u/l
43.2
40.1
—
5
63
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
9
72
1.26
0.26
4.1
3.5
mmol/l
2.9
1.3
—
9
53
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
9
76
1.19
0.25
4.1
3.5
kpa
5.2
5.0
—
9
70
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
82
0.72
0.24
7.2
4.4
mmol/l
24.4
25.0
—
6
82
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
24
274
0.86
0.24
1.6
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
15
179
0.82
0.24
4.3
7.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
125
0.79
0.23
2.0
1.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
85
806
1.10
0.23
6.3
5.9
e9/l
2.0
1.9
0.34
76
716
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
39
1.29
0.23
1.4
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
40
1.26
0.22
2.0
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
16
188
0.84
0.22
1.3
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
60
560
1.10
0.22
5.5
7.1
inr
1.1
1.2
0.47
12
166
(3003338) MCHC [Mass/volume]
144
1401
1.11
0.22
16.7
15.9
g/l
333.4
333.3
0.03
144
1396
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
41
1.23
0.22
1.6
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
41
1.23
0.22
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
41
1.23
0.22
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
41
1.23
0.22
1.6
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
102
0.78
0.21
2.1
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
42
385
1.12
0.21
2.2
3.0
ng/l
630.4
1008.1
1.16
33
323
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
26.8
—
0
10
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.3
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
12
0.00
0.21
0.0
1.5
—
24.1
—
0
12
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
12
0.00
0.21
0.0
1.8
—
13.2
—
0
12
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
12
0.00
0.21
0.0
2.1
—
100.2
—
0
12
(1617658) Protocol used for examination of sentinel lymph nodes
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
3.8
—
86.8
—
0
13
(3017143) Hepatitis C virus Ab [Presence] in Serum
19
218
0.86
0.20
1.3
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
48
1.26
0.20
1.2
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
6
49
1.23
0.20
2.0
2.2
—
7600.1
—
0
13
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
35
319
1.12
0.19
1.4
1.7
mg/l
1.1
1.1
0.01
26
242
(3001604) Monocytes [#/volume] in Blood
82
781
1.09
0.19
6.2
5.9
e9/l
0.7
0.6
1.39
75
678
(3019832) Treponema pallidum Ab [Presence] in Serum
20
175
1.16
0.19
1.6
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
40
368
1.11
0.19
2.7
4.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
52
1.16
0.19
1.0
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
15
128
1.19
0.19
2.6
3.7
kpa
5.9
5.7
0.18
15
123
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
121
0.82
0.18
1.2
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
7
62
1.13
0.17
1.9
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
64
608
1.08
0.16
2.0
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
76
0.78
0.16
1.7
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
76
0.78
0.16
1.7
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
75
0.79
0.16
1.7
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
78
0.76
0.16
1.0
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
79
1.15
0.15
1.2
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
79
1.15
0.15
1.0
1.6
—
—
—
0
0
(3000492) Spirometry study
13
150
0.86
0.15
1.9
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
89
0.78
0.15
1.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
111
1079
1.07
0.14
2.7
3.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
45
426
1.07
0.12
4.3
4.1
mg/mmol
4.3
9.6
0.86
26
255
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
4.4
2.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
5
46
1.09
0.09
2.6
2.5
—
1.4
—
0
5
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
5
46
1.09
0.09
2.4
2.5
mg/l
18.2
32.5
—
5
38
(3034860) Kappa light chains.free [Mass/volume] in Serum
5
46
1.09
0.09
2.4
2.5
mg/l
29.4
207.8
—
5
37
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
42
400
1.06
0.09
2.0
1.7
mmol/l
1.4
1.4
0.03
34
341
(3013650) Neutrophils [#/volume] in Blood by Automated count
89
913
0.95
0.09
9.0
9.4
e9/l
4.1
4.1
0.02
81
798
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
56
1.07
0.09
1.3
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
25
234
1.08
0.08
1.7
2.3
—
—
—
0
0
(1002224) Polysomnography panel
6
70
0.85
0.08
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
74
0.80
0.07
1.7
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
8
74
1.08
0.07
7.8
7.6
%
92.9
94.2
—
8
74
(40758558) Short blood count panel - Blood
39
407
0.95
0.07
5.7
7.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
8
76
1.05
0.07
2.3
3.3
g/l
134.8
128.2
—
8
76
(3036481) Cortisol [Moles/volume] in Serum or Plasma
16
147
1.10
0.07
3.7
2.0
nmol/l
397.4
372.0
0.24
16
136
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
108
1.12
0.07
1.0
1.2
iu/ml
43.0
108.6
—
5
43
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
31
326
0.94
0.07
1.8
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
80
0.87
0.07
1.4
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
22
233
0.94
0.06
3.1
2.7
e6/l
0.6
2.2
1.53
14
127
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
172
0.92
0.06
1.7
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
48
495
0.96
0.05
2.4
3.3
mmol/l
2.4
2.4
0.44
41
435
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
19
180
1.06
0.04
1.6
2.7
umol/l
4.6
10.2
1.56
14
159
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
11
102
1.08
0.03
1.7
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
150
1490
1.03
0.03
9.9
11.6
ml/min/173m2
85.9
84.5
0.28
115
1192
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
13
138
0.94
0.02
2.4
2.2
g/l
0.2
0.2
0.31
13
126
(40768797) Stomach Pathology biopsy report
20
192
1.05
0.02
1.3
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
44
449
0.97
0.02
3.9
3.1
mmol/l
7.1
7.8
0.64
36
376
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
25
242
1.04
0.02
1.4
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
24
248
0.96
0.02
3.0
2.5
e6/l
2.9
0.8
0.47
16
141
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
160
1592
1.03
0.02
12.6
12.4
mg/l
18.2
22.3
1.08
124
1213
(3014111) Lactate [Moles/volume] in Serum or Plasma
11
117
0.94
0.02
6.0
4.9
mmol/l
1.1
1.4
0.85
11
111
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
22
213
1.04
0.01
1.5
2.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
41
403
1.02
0.01
4.3
3.4
mg/l
43.5
52.3
0.11
21
251
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
57
563
1.02
0.01
2.4
3.5
ng/l
14.2
27.3
4.08
32
369
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
10
104
0.96
0.00
1.1
1.3
—
31.3
—
0
5
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
10
99
1.01
0.00
2.7
3.7
pmol/l
4.5
4.8
—
10
86
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
25
254
0.98
0.00
1.3
1.3
u/ml
1.2
6.2
—
7
104
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
29
286
1.02
0.00
3.3
2.8
ug/l
0.7
0.8
0.11
19
187
(21494755) Public health laboratory ask at order entry panel
18
179
1.01
0.00
1.5
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
33
331
1.00
0.00
3.7
3.7
kg/l
1.0
1.0
—
9
46
(3013826) Glucose [Moles/volume] in Serum or Plasma
88
879
1.00
0.00
4.8
4.1
mmol/l
6.8
6.6
0.26
76
816
(3022145) Colonoscopy Study observation
17
167
1.02
0.00
1.1
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
17
173
0.98
0.00
2.0
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
19
187
1.02
0.00
2.5
2.2
%
22.2
25.5
0.45
12
163
(3026008) Bacteria identified in Urine by Culture
41
413
0.99
0.00
3.0
2.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
44
438
1.01
0.00
1.3
1.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
11
105
1.05
0.00
1.9
2.7
kpa
4.5
4.6
0.07
11
99
(40761535) Cells panel - Urine sediment
10
95
1.06
0.00
1.7
3.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
9
0.00
0.00
0.0
2.4
—
6.4
—
0
9
(3035933) Granulocytes/100 leukocytes in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
4.8
—
213.0
—
0
8
(3050129) First trimester maternal screen panel - Serum or Plasma
5
53
0.94
0.00
1.4
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
49
1.02
0.00
3.6
3.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.8
—
67.0
—
0
6
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
137.9
—
0
7
(3000330) Specific gravity of Urine by Test strip
7
77
0.91
0.00
2.1
3.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
3.8
—
0
5
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
9
90
1.00
0.00
2.3
2.2
—
—
—
0
0
(4034850)
5
56
0.89
0.00
8.4
10.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
31.1
—
0
6
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
24.0
—
0
5
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
54
0.92
0.00
2.4
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1662.4
—
0
5
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
72
0.97
0.00
3.0
1.7
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
8
0.00
0.00
0.0
2.4
—
126.1
—
0
8
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
91.3
—
0
8
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.9
—
5.0
—
0
8
(3016879) Cocaine [Presence] in Urine
6
69
0.87
0.00
1.7
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.0
—
39.3
—
0
8
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
7
0.00
0.00
0.0
2.0
—
24.0
—
0
7
Mortality – FinRegistry
↥Association
Association between endpoint H8_DISCON and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have H8_DISCON.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: H8_DISCON – Discontinuity and dislocation of ear ossicles
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data